Possible distribution or partnerships/ takeovers (Hypothetical only), page-56

Reposted as I made a mistake in total ordinary shares.

Company presentation states as of the 29/11/2018:

Total ordinary shares 828,662,398 shares.

Recent raise was for 3.3m before costs which would make it close to 165m shares at a price of 0.02 making it a total of 993,662,398

I’m no account but my numbers actually show when working with numbers from the short fall:

164,917,060 shares diluted totaling 993,579,458.

The 3.3m is before costs.

Again my maths and I’m not an account and I’m not sure of any extra costs or what bracket they’ll be charge and in what country or both.

They should end up with $2,409,000 plus the $1.13m they had on the 28/11/2018 = $3,539,000.

What this means for the SP, we’ll have to wait and see and the MC will reflect that.

I’d be leaning more towards BD1 moving north soon rather than drifting to much more south.

It is December though and the markets shocking.

Vaccine news any day now.

Possibly an improved Breast cancer test result

Thermofisher platform completion.

What does this mean for the SP???????

Again much to do over the next couple of years and there’s going to be plenty of opportunities to get out if trapped or increase your wealth if that’s your plan.

For those that read my post on what it takes to get a blood test to market will hopefully understand that if BD1 achieve this what the SP could possibly be.

Don’t quote me on this and please post if you have more accurate figures.